PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 22, 2026Nature Chemical Biology2 citationsOpen Access

Xylosyltransferase engineering to manipulate proteoglycans in mammalian cells

View Full Paper
ZLZhen LiHCHimanshi ChawlaLVLucia Di Vagno

Key Points

  • The research aims to develop a strategy to control the glycosylation of proteoglycans in mammalian cells by engineering xylosyltransferases.
  • Developed a chemical genetic strategy utilizing a bump-and-hole tactic.
  • Engineered xylosyltransferases XT1 and XT2 to transfer a chemically tagged xylose analog, 6AzGlc.
  • Implemented mass spectrometry to pinpoint glycosylation sites and visualize target proteins.
  • Successfully transferred 6AzGlc to target proteins in mammalian cells.
  • Established the chemical handle for manufacturing proteoglycans with defined glycosaminoglycan chains.
  • Provided new insights into proteoglycan biology using conventional biochemistry techniques.

Abstract

Abstract Mammalian cells receive signaling instructions through interactions on their surfaces. Proteoglycans are critical to these interactions, carrying long glycosaminoglycans that recruit signaling molecules. Biosynthetic redundancy in the first glycosylation step by two xylosyltransferases XT1/2 complicates annotation of proteoglycans. Here we develop a chemical genetic strategy that manipulates the glycan attachment site of cellular proteoglycans. Through a bump-and-hole tactic, we engineer the two isoenzymes XT1 and XT2 to specifically transfer the chemically tagged xylose analog 6AzGlc to target proteins. The tag contains a bioorthogonal functionality, allowing to visualize and profile target proteins in mammalian cells. Unlike xylose analogs, 6AzGlc is amenable to cellular nucleotide-sugar biosynthesis, establishing the XT1/2 bump-and-hole tactic in cells. The approach allows pinpointing glycosylation sites by mass spectrometry and exploiting the chemical handle to manufacture proteoglycans with defined glycosaminoglycan chains for cellular applications. Engineered XT enzymes permit an orthogonal view into proteoglycan biology through conventional techniques in biochemistry.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/6971bd4c642b1836717e1faahttps://doi.org/10.1038/s41589-025-02113-w
Ask AI
Helpful
Bookmark
Share
View Full Paper